LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

Victoria Acquires Controlling Stake in Oncólogos del Occidente

26 June 2017

Victoria Capital Partners acquired a controlling stake in Oncólogos del Occidente, Colombia’s largest privately-held provider of comprehensive cancer treatment. Terms of the transaction were not disclosed.

(Press Release) BOGOTA – June 26, 2017 – Victoria Capital Partners (“VCP”) announced today a significant growth capital investment in Oncólogos del Occidente (“ODO”), Colombia’s largest privately-held provider of comprehensive cancer treatment, acquiring a controlling stake in ODO. As part of the transaction, Victoria also made a capital injection in ODO that will be used to support and accelerate ODO’s continued growth in Colombia through the development of three new integrated cancer treatment centers. This capital injection will be used to strengthen the capital structure of the company and support its current growth plan, aiming at doubling its size over the next four years. Simultaneously, VCP acquired a block of additional shares from the ODO shareholders. As a result, Victoria will be ODO’s controlling shareholder, with the founders continuing as minority shareholders focused on serving patients. Specific terms of the transaction were not disclosed.

Ricardo Vazquez, Partner of VCP in Bogota said: “We are very excited about our investment in Oncólogos del Occidente and to be partnering with such highly recognized and accomplished physicians that founded the company 25 years ago. Over the years, Oncólogos has developed a strong sector presence in Colombia’s cancer treatment segment with a comprehensive cancer service model characterized by its widely-recognized high quality standards. We believe Oncólogos is uniquely positioned to seize the opportunities in the under-penetrated and growing cancer segment of the Colombian healthcare market through an aggressive investment plan. In that regard, we believe that Oncólogos will benefit from our experience as controlling shareholders of Grupo Oncoclínicas, the leading privately-held provider of cancer treatment in Brazil, as we seek to lead Oncólogos into its next growth and consolidation stage.

Founded in 1992, ODO is the largest privately-held provider of comprehensive cancer treatment in Colombia. ODO has an integrated service model, offering all services related to the oncology specialty. The company provides integral cancer treatment in 4 states in Colombia clustered in the central west region of the country (Colombia´s coffee growing area) representing roughly 10% of the national population or nearly 4 million people. In those four states ODO reaches an average of over 90% of the population. ODO covers its area of influence with a network of 7 integrated modern facilities (4 outpatient care and 3 hospitalization clinics) in 4 different cities. The comprehensive range of oncology-focused services provided to its patients include imaging diagnosis, clinical laboratory, radiotherapy (including IMRT, high dose brachytherapy or internal radiotherapy and radio surgery), chemotherapy, oncology hospitalization and surgery, palliative care and pain clinic, psycho-oncology and clinical research, for both pediatric and adult patients. Additionally, ODO supports its oncology operation by offering non-oncologic health services, including hospitalization, high-complexity surgery, critical and intensive care units, imaging diagnosis and clinical laboratory.

Victoria Acquires Controlling Stake in Oncólogos del Occidente was last modified: July 11th, 2017 by Editor
Cancer TreatmentColombiaHealth ServicesHealthcareOncólogos del OccidentePrivate EquityVictoria Capital Partners
0
Facebook Twitter Google +

Tech Growth Membership

The 2023 LAVCA Startup Founders Survey is made possible thanks to the support of LAVCA’s Tech Growth Membership, a group of leading tech companies and investors advancing the tech ecosystem in Latin America including AWS, Mercado Libre, Microsoft, Qualcomm Ventures, SVB, Riverwood Capital, Google and Movile.

VC Partner Events

    Tweets

    Missing consumer key - please check your settings in admin > Settings > Twitter Feed Auth

    Submit VC News

    Have private equity or venture capital related news that you would like to share? Submit your press releases and news to [email protected].

    VC Industry News

    • Valor Capital Group and NFX Co-Lead USD9.3m Series A for Brazil’s Praso

      30 August 2023
    • EQT Growth Leads USD85m Series F for Brazil’s Gympass at USD2.2b Valuation

      23 August 2023
    • Tiger Global Leads USD61m Series B for Brazil’s Nomad 

      22 August 2023
    • NASZCA and IDB Invest Lead USD15.5m Series A for Mexico’s Wonder Brands

      17 August 2023
    • Victory Park Capital Provides USD100m Credit Facility for Mexico’s Klar

      15 August 2023
    • General Catalyst Lead USD45m Series B for Brazil’s Tractian

      7 August 2023
    • General Catalyst Leads USD45m Round for Brazil’s Tractian

      7 August 2023
    • ADQ Provides USD100m In Convertible Debt to Brazil’s Loft

      2 August 2023
    • Danish SDG Investment Fund Leads USD31.5m Series C for Mexico’s Bright  

      27 July 2023
    • Colombia’s Foodology Raises USD17m from Andreessen Horowitz, 30N Ventures and Chimera

      19 July 2023

    About LAVCA

     

    LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

    LAVCA Office

        New York City:
        589 8th Ave, 18th Floor
        New York, NY 10018

    Explore LAVCA.org

    • About LAVCA
    • Board, Team, & Advisors
    • Media
    • Contact Us
    • Membership Benefits
    • Members Only Access
    • Education and Programs
    • Research
    • Policy
    • LAVCA VC
    • Contact Us

    @2020 - LAVCA. All Rights Reserved.


    Back To Top